Bioscience solutions

In recent years, there has been a strong need in the medical field to respond to the aging of the population, the increase in chronic diseases, pandemics, and infectious diseases.
artience group will provide a wide range of materials and services for research and development, drug discovery, screening, and testing and therapeutics, with the goal of delivering hope to all patients and their families. Through the provision of these materials and services, we aim to contribute to solving issues in the medical field, such as the early detection of diseases and the improvement of the quality of life of consumers, and to realize a society where people can live fulfilling lives.

For more information on artience group's biotechnology, please refer to the following pages:

Technology Platform: Bio

• Bioscience business policy and development system
• artience bioscience solutions

Bioscience business policy and development system

artience has identified the creation of the bioscience business as one of the next-generation businesses in Basic Policy 2 "Creation of Strategic Priority Businesses" of the Management Plan artience 2027/2030 "GROWTH."
artience 's biotechnology business is led by the Biotech Business Unit of the artience Co., Ltd. Incubation Center, which promotes market development and product development, and develops its product group as a Sciforiem™.

Development system

artience bioscience solutions

artience group offers a variety of bioscience-based solutions centered on the medical field.

Functional polymers for in vitro diagnostics

Advanced molecular design technology contributes to higher sensitivity, speed, and stabilization of in vitro diagnostics

Near-infrared fluorescent probe for high-sensitivity imaging

Contributing to regenerative medical technology and cancer research by realizing microscopic areas and long-term observation

Share

Print